Firm
Niri Shan, the newly appointed head of IP for UK, Ireland and the Middle East, explains why the firm’s international setup has brought UPC success, and addresses German partner departures
Stobbs stands accused of interfering with the administration of justice after Brandsmiths’ client was subjected to an interim injunction for unjustified threats
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
Rebecca Schwarz at Haynes Boone shares how her team secured victory for biopharma client RedHill in a licensing dispute involving a developmental cancer drug
Sponsored
Sponsored
-
Sponsored by Wanhuida Intellectual PropertyHonghui Hu of Wanhuida Intellectual Property explains that a CNIPA ruling on a patent covering an antidepressant could help to determine the patentability of pharmaceutical compounds
-
Sponsored by Maiwald Intellectual PropertyGisela Grabow of Maiwald considers the potential changes to the EU’s general pharmaceutical legislation under a recent proposal, and the main questions raised for stakeholders
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law reports on South Korea’s bid to lead the way on autonomous vehicles with a streamlined patent process.
-
Sponsored by Tilleke & GibbinsLoc Xuan Le of Tilleke & Gibbins reviews two thought-provoking Vietnamese IP cases, with potentially far-reaching implications for the country’s IP enforcement system.
-
Sponsored by RNA, Technology and IP AttorneysRanjan Narula and Shipra Alisha Philip of RNA Technology and IP Attorneys underline the importance of trademark protection in a booming nutraceuticals market in India and explain what steps brand owners should take
-
Sponsored by InspicosJakob Pade Frederiksen of Inspicos says that clarification from the EPO Enlarged Board of Appeal may be necessary after a series of rulings concerning the format of oral proceedings in appeals